Infection with influenza A virus (IAV) presents a substantial threat to public health worldwide, with young, elderly, and immunodeficient individuals being particularly susceptible. Inflammatory responses play an important role in the fatal outcome of IAV infection, but the mechanism remains unclear. We demonstrate here that the absence of invariant NKT (iNKT) cells in mice during IAV infection resulted in the expansion of myeloid-derived suppressor cells (MDSCs), which suppressed IAV-specific immune responses through the expression of both arginase and NOS, resulting in high IAV titer and increased mortality. Adoptive transfer of iNKT cells abolished the suppressive activity of MDSCs, restored IAV-specific immune responses, reduced IAV titer, and increased survival rate. The crosstalk between iNKT and MDSCs was CD1d- and CD40-dependent. Furthermore, IAV infection and exposure to TLR agonists relieved the suppressive activity of MDSCs. Finally, we extended these results to humans by demonstrating the presence of myeloid cells with suppressive activity in the PBLs of individuals infected with IAV and showed that their suppressive activity is substantially reduced by iNKT cell activation. These findings identify what we believe to be a novel immunomodulatory role of iNKT cells, which we suggest could be harnessed to abolish the immunosuppressive activity of MDSCs during IAV infection.
Carmela De Santo, Mariolina Salio, S. Hajar Masri, Laurel Yong-Hwa Lee, Tao Dong, Anneliese O. Speak, Stefan Porubsky, Sarah Booth, Natacha Veerapen, Gurdyal S. Besra, Hermann-Josef Gröne, Frances M. Platt, Maria Zambon, Vincenzo Cerundolo
Title and authors | Publication | Year |
---|---|---|
Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models
H Wang, D Tumes, T Hercus, K Yip, C Aloe, R Vlahos, A Lopez, N Wilson, C Owczarek, S Bozinovski |
Cell Death and Disease | 2022 |
Mast Cell Activation Triggered by Retrovirus Promotes Acute Viral Infection
Shu-Ting Song, Meng-Li Wu, Hai-Jiao Zhang, Xiao Su, Jian-Hua Wang |
Frontiers in microbiology | 2022 |
Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
Y Li, Z Dunn, G Garcia, C Carmona, Y Zhou, D Lee, J Yu, J Huang, J Kim, V Arumugaswami, P Wang, L Yang |
Stem Cell Research & Therapy | 2022 |
Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression
Nelson A, Gebremeskel S, Lichty BD, Johnston B |
Journal for ImmunoTherapy of Cancer | 2022 |
Cross Talk Between Natural Killer T and Dendritic Cells and Its Impact on T Cell Responses in Infections.
Zhao L, Yang X |
Frontiers in immunology | 2022 |
Ingestion, Immunity, and Infection: Nutrition and Viral Respiratory Tract Infections
Govers C, Calder PC, Savelkoul HF, Albers R, van Neerven RJ |
Frontiers in immunology | 2022 |
Myeloid-derived suppressor cells in COVID-19: A review
Perfilyeva YV, Ostapchuk YO, Tleulieva R, Kali A, Abdolla N, Krasnoshtanov VK, Perfilyeva AV, Belyaev NN |
Clinical Immunology | 2022 |
Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment
Delfanti G, Dellabona P, Casorati G, Fedeli M |
Frontiers in Medicine | 2022 |
Immature granulocytes: Innovative biomarker for SARS-CoV-2 infection
Georgakopoulou VE, Makrodimitri S, Triantafyllou M, Samara S, Voutsinas PM, Anastasopoulou A, Papageorgiou CV, Spandidos DA, Gkoufa A, Papalexis P, Xenou E, Chelidonis G, Sklapani P, Trakas N, Sipsas NV |
Molecular medicine reports | 2022 |
Evaluating α-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs
Artiaga BL, Morozov I, Ransburgh R, Kwon T, Balaraman V, Indran SV, De Carvalho Madrid DM, Gu W, Henningson J, Ma W, Richt JA, Driver JP |
2022 | |
Invariant natural killer T cells minimally influence gut microbiota composition in mice.
Lin Q, Kuypers M, Liu Z, Copeland JK, Chan D, Robertson SJ, Kontogiannis J, Guttman DS, Banks EK, Philpott DJ, Mallevaey T |
Gut microbes | 2022 |
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.
Stavrou V, Fultang L, Booth S, De Simone D, Bartnik A, Scarpa U, Gneo L, Panetti S, Potluri S, Almowaled M, Barlow J, Jankevics A, Lloyd G, Southam A, Priestman DA, Cheng P, Dunn W, Platt F, Endou H, Craddock C, Keeshan K, Mussai F, De Santo C |
Cancer Immunology, Immunotherapy | 2022 |